Next Article in Journal
Progression-Free Survival as a Clinical Trial Endpoint in Advanced Renal Cell Carcinoma
Previous Article in Journal
Models of Care for Early-Stage Breast Cancer in Canada
 
 
Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
Journals
Current Oncology
Volume 18
Issue i0
10.3747/co.v18i0.899
curroncol-logo
Submit to this Journal Review for this Journal Propose a Special Issue
► Article Menu

Article Menu

share Share announcement Help format_quote Cite question_answer Discuss in SciProfiles thumb_up
...
Endorse textsms
...
Comment
Current Oncology is published by MDPI from Volume 28 Issue 1 (2021). Previous articles were published by another publisher in Open Access under a CC-BY (or CC-BY-NC-ND) licence, and they are hosted by MDPI on mdpi.com as a courtesy and upon agreement with Multimed Inc..
first_page
settings
Order Article Reprints
Font Type:
Arial Georgia Verdana
Font Size:
Aa Aa Aa
Line Spacing:
Column Width:
Background:
Article

Patient Adherence to Aromatase Inhibitor Treatment in the Adjuvant Setting

by
S. Verma
1,*,
Y. Madarnas
2,
S. Sehdev
3,
G. Martin
4 and
J. Bajcar
5
1
Toronto–Sunnybrook Regional Cancer Centre, Division of Medical Oncology, Sunnybrook and Women’s College Health Sciences Centre, Toronto, ON, Canada
2
Kingston Regional Cancer Centre, Kingston, ON, Canada
3
The Oncology Group, William Osler Health Centre, Brampton, ON, Canada
4
Department of Surgery, Centre Hospitalier de l’Université de Montréal, Montréal, QC, Canada
5
Sunnybrook Health Sciences Center, Department of Pharmacy, Toronto, ON, Canada
*
Author to whom correspondence should be addressed.
Curr. Oncol. 2011, 18(i0), 3-9; https://doi.org/10.3747/co.v18i0.899
Submission received: 6 April 2011 / Revised: 9 April 2011 / Accepted: 13 April 2011 / Published: 1 May 2011

Abstract

Improvements in adjuvant systemic therapy and detection of early disease have resulted in a decline of breast cancer death rates across all patient age groups in Canada. Non-adherence to adjuvant hormonal therapy in the setting of early breast cancer may significantly affect patient outcome. Factors associated with medication adherence are complex and may be patient-related, therapy-related, and health care provider–related. To date, there is a gap in the literature concerning a comprehensive understanding of factors related to medication adherence with anti-estrogen therapy in the adjuvant setting. The literature suggests that strategies for improving adherence should focus on education of patients, assessment of the ability of patients to understand their disease and related recurrence factors, and facilitation of adherence by patients by providing adequate support and strategies for good self-management. However, more research is needed to better understand how health care providers can support women with breast cancer on oral therapy in the adjuvant setting.
Keywords: adherence; hormone receptor—positive breast cancer; adjuvant hormonal therapy; aromatase inhibitors; tamoxifen adherence; hormone receptor—positive breast cancer; adjuvant hormonal therapy; aromatase inhibitors; tamoxifen

Share and Cite

MDPI and ACS Style

Verma, S.; Madarnas, Y.; Sehdev, S.; Martin, G.; Bajcar, J. Patient Adherence to Aromatase Inhibitor Treatment in the Adjuvant Setting. Curr. Oncol. 2011, 18, 3-9. https://doi.org/10.3747/co.v18i0.899

AMA Style

Verma S, Madarnas Y, Sehdev S, Martin G, Bajcar J. Patient Adherence to Aromatase Inhibitor Treatment in the Adjuvant Setting. Current Oncology. 2011; 18(i0):3-9. https://doi.org/10.3747/co.v18i0.899

Chicago/Turabian Style

Verma, S., Y. Madarnas, S. Sehdev, G. Martin, and J. Bajcar. 2011. "Patient Adherence to Aromatase Inhibitor Treatment in the Adjuvant Setting" Current Oncology 18, no. i0: 3-9. https://doi.org/10.3747/co.v18i0.899

APA Style

Verma, S., Madarnas, Y., Sehdev, S., Martin, G., & Bajcar, J. (2011). Patient Adherence to Aromatase Inhibitor Treatment in the Adjuvant Setting. Current Oncology, 18(i0), 3-9. https://doi.org/10.3747/co.v18i0.899

Article Metrics

Back to TopTop